Technetium-99m hexamethylpropylene amine oxime lung scintigraphy findings in low-dose amiodarone therapy

Lung

Volumn 184, Issue 2, 2006, Pages 57-61

  Kaya, G Capa ^a   Ertay, T ^a   Tuna, B ^a   Bekis, R ^a   Tasci, C ^a   Sayit, E ^a   Yilmaz, O ^a   Kargi, A ^a   Durak, H ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Amiodarone; Inflammation; Lung; Tc 99m HMPAO; Toxicity

Indexed keywords

AMIODARONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; KETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCULATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; LIVER; LONG TERM CARE; LONGITUDINAL STUDY; LOW DRUG DOSE; LUNG; LUNG SCINTISCANNING; LUNG TOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; FEMALE; LIVER; LUNG; LUNG DISEASES; MODELS, BIOLOGICAL; RABBITS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 33645972262     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-005-2562-3     Document Type: Article

References (30)

1. Braunwald E (1997) Heart Disease. A Textbook of Cardiovascular Medicine, 5th ed. W.B. Saunders, Philadelphia, pp 613-615
2. Camus P, Martin WJ, Rosenow EC (2004) Amiodarone pulmonary toxicity. Clin Chest Med 25:65-75
3. Capa Kaya G, Bekis R, Kirimca F, et al. (2001) Use of technetium-99m HMPAO scintigraphy for the detection of amiodarone lung toxicity in a rabbit model. Eur J Nucl Med 28:346-350
4. Chang C-H, Wu H-C, Tsai J-JP, et al. (2003) Usefulness of technetium-99m hexamethylpropylene amime oxime lung scan to detect subclinical lung injury in patients with chronic renal failure. Lung 181:97-101
5. Cooper JAD, White DA, Matthay RA (1986) Drug-induced pulmonary disease. Part 2: noncytotoxic drugs. Am Rev Respir Dis 133:488-505
6. Dirlik A, Erinc R, Ozcan Z, et al. (2002) Technetium-99m-DTPA aerosol scintigraphy in amiodarone-induced pulmonary toxicity in comparison with Ga-67 scintigraphy. Ann Nucl Med 16:477-481
7. Durak H, Kilinc O, Ertay T, et al. (2003) Tc-99m-HMPAO uptake by bronchoalveolar cells. AnnNucl Med 17:107-113
8. Durmus-Altun G, Altun A, Sami Salihoglu Y, et al. (2004) Value of technetium-99m diethyltriamine pentaaceticacid radioaerosol inhalation lung scintigraphy for the stage of amiodarone-induced pulmonary toxicity. Int J Cardiol 95:193-197
9. Evans SJ, Myers M, Zaher J, et al. (1992) High dose oral amiodarone loading: Electrophysiologic effects and clinical tolerance. J Am Coll Cardiol 19:169-173
10. Gunaydin B, Karadenizli Y, Babacan A, et al. (1997) Pulmonary microvascular injury following general anesthesia with volatile anesthetics-halothane and isoflurane: a comparative clinical and experimental study. Respir Med 91:351-360
11. Hardman JG, Limbird LE (2001) Goodman & Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp 953-957
12. Hilbert H, Mohsenin V (1996) Adaptation of lung antioxidants to cigarette smoking in humans. Chest 110:916-920
13. Hilleman D, Miller MA, Parker R, et al. (1998) Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy 18:1388-1458
14. Hung C-J, Liu F-Y, Shaiu Y-C, et al. (2003) Assessing transient pulmonary injury induced by volatile anesthetics by increased lung uptake of technetium-99m hexamethylpropylene amimie oxime. Lung 181:1-7
15. Kalbfieisch SJ, Williamsøn B, Man KC, et al. (1993) Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia. J Am Coll Cardiol 22:1723-1729
16. Kim SG, Mannino MM, Chou R, et al. (1992) Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. Ann Intern Med 117:197-201
17. Latorre G, Lucas I, Herrero JI, et al. (1999) Severe hepatotoxicity caused by amiodarone: description of a case. Rev Med Univ Navarra 43:86-91
18. Meyers JL (1997) Pathology of drug-induced lung disease. In: Katzenstein AA, Askin FB (eds) Katzenstein and Askin's surgical pathology of non-neoplastic lung disease Vol 4. W.B. Saunders, Philadelphia, pp 81-111
19. Roca J, Heras M, Rodriguez-Roisin R, et al. (1992) Pulmonary complications after long term amiodarone treatment. Thorax 47:372-376
20. Rossi SE, Erasmus JJ, McAdams HP, et al. (2000) Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 20:1245-1259
21. Rotmensch HH, Liron M, Tupilsky M, et al. (1980) Possible association of pneumonitis with amiodarone therapy. Am Heart J 100:412-413
22. Shih WJ, Gruenwald F, Biersack HJ, et al. (1991) Tc-99m HMPAO diffuse pulmonary uptake demonstrated in cigarette smokers. Clin Nucl Med 16:668-672
23. Shih WJ, Rehm SR, Gruenwald F, et al. (1993) Lung uptake of Tc-99m HMPAO in cigarette smokers expressed by lung/liver activity ratio. Clin Nucl Med 18:227-230
24. Spaniol M, Bracher R, Ha HR, et al. (2001) Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. Hepatology 35:628-636
25. Suga K, Uchisako, Nishigauchi K, et al. (1994) Technetium-99m-HMPAO as a marker of chemical and irradiation lung injury: experimental and clinical investigations. J Nucl Med 35:1520-1527
26. Summitt J, Morady F, Kadish A (1992) A comparison of standard and high-dose regimens for the initiation of amiodarone therapy. Am Heart J 124:366-373
27. 99m Tc-HMPAO scintigraphy for irradiated lung in rabbits: detection of pulmonary microvascular injury. Nippon Igaku Hoshasen Gakkai Zasshi 53:835-846
28. Ulrik CS, Backer V, Aldlershvile J, et al. (1992) Serial pulmonary function tests in patients treated with low-dose amiodarone. Am Heart J 123:1550-1554
29. Weinberg BA, Miles WM, Klein LS, et al. (1993) Five-year follow-up of 589 patients treated with amiodarone. Am Heart J 125:109-120
30. Zhu YY, Botninick E, Dae M, et al. (1988) Gallium lung scintigraphy in amiodarone lung toxicity. Chest 93:1126-1131